Tuesday, April 09, 2024 7:04:04 PM
Recent GOSS News
- Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference • Business Wire • 05/14/2024 08:01:00 PM
- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/10/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:02:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:01:53 PM
- Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/07/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 11:31:01 AM
- Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications • Business Wire • 05/06/2024 11:30:00 AM
- Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine • Business Wire • 05/03/2024 12:02:00 PM
- Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors • Business Wire • 03/12/2024 11:31:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/05/2024 12:37:14 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 12:32:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:31:51 PM
- Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update • Business Wire • 03/05/2024 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:02:26 PM
- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/08/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:11:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:04:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:02:36 PM
- Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023 • Business Wire • 12/13/2023 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:12:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:09:55 PM
- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 12/05/2023 09:01:00 PM
- Gossamer Bio Appoints Bob Smith as Chief Commercial Officer • Business Wire • 12/05/2023 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:01:22 PM
- Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors • Business Wire • 11/29/2023 12:01:00 PM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM